FOXP1 and myelodysplastic syndrome: We then performed MethylTarget sequencing of bone marrow samples from 156 human subjects, including 103 patients with AML, 28 patients with MDS, and 25 healthy controls to analyze the status of DNA methylation of 1 CpG sites of FOXP1 gene promoter (chr3: 71542279).